# Edgene Biot

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/edgene-biot

- Industry: Biotechnology
- Headquarters: Wuhan, China
- Website: www.edgene.com.cn
- Latest round: Angel (Oct 25, 2022)
- Investors on record: 2

## About

Established in 2019 and based in Wuhan, China, Edgene Biot operates as a digital precision breeding technology and service provider that focuses on biological breeding technology. The company's office and experimental area cover 1600 square meters. Edgene Biot has 60 employees. 
In September 2025, Edgene Biot closed pre-series A funding from new investor Hi-Tech Agri. Group.

The business of the company includes gene function research service, bio breeding CRO service, variety development and management. Its platform divided into gene editing platform, molecular biology platform, plant genetic transformation platform, field experiment and screening. Gene editing platform includes gene editing vector construction, gene editing vector genetic transformation system, gene editing target mutation detection and miss detection. Molecular biology platform includes gene precise editing system, gene regulation vector construction system, gene cloning and expression analysis system, and protein function identification system. The company generates revenue from providing biological breeding technology.

The pre-series A financing will be used by the company to further promote innovation and application in digital precision breeding.

## Funding rounds

- Angel, Oct 25, 2022 — Yonghua Capital, Jifeng Ventures

## Investors

- Yonghua Capital (https://capitalatlas.ai/funds/yonghua-capital) — Angel
- Jifeng Ventures (https://capitalatlas.ai/funds/jifeng-ventures) — Angel